bioRxivCell Biology
A Chemical Toolbox for the Study of Bromodomains and Epigenetic Signaling
Q. Wu, D. Heidenreich, S. Zhou, S. Ackloo, G. Deblois, S. Duan, K. Nakka, J. Dilworth, M. Lupien, P. E. Brennan, C. H. Arrowsmith, S. Mueller, O. Fedorov, P. Filippakopoulos, S. Knapp
Abstract
Bromodomains (BRDs) are evolutionary conserved epigenetic protein interaction modules which recognize (\"read\") acetyl-lysine, however their role(s) in regulating cellular states and their potential as targets for the development of targeted treatment strategies is poorly understood. Here we present a set of 25 chemical probes, selective tool small molecule inhibitors, covering 29 human bromodomain targets. We comprehensively evaluate the selectivity of this probe-set using BROMOscan(R) and demonstrate the utility of the set using studies of muscle cell differentiation and triple negative breast cancer (TNBC). We identified cross talk between histone acetylation and the glycolytic pathway resulting in a vulnerability of TNBC cell lines to inhibition of BRPF2/3 BRDs under conditions of glucose deprivation or GLUT1 inhibition. This chemical probe set will serve as a resource for future applications in the discovery of new physiological roles of bromodomain proteins in normal and disease states, and as a toolset for bromodomain target validation.
- organism: human
- research focus: drug response / drug discovery
- research focus: chromatin & epigenetic regulation
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of novel Bromodomain inhibitors of Trypanosoma cruzi Bromodomain Factor 2 (TcBDF2) using a fluorescence polarization-base high-throughput assay
Esteban Carlos Serra, Luis Tavernelli, … Raquel Gabarro·Antimicrobial Agents and ChemotherapyPeer-reviewed·Jul 19, 2024
- NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells
Molly Sneddon, Chi-Ming Tsou, … William C. K. Pomerantz·Bioconjugate ChemistryPeer-reviewed·Mar 4, 2026
- Chemoproteomics Enabled Discovery of Selective Probes for NuA4 Factor BRD8
D. Remillard, N. A. Savage, … W. C. Forrester·bioRxiv·Feb 22, 2021
- Therapeutic potential of TAF1 bromodomains for cancer treatment
Veronica Garcia-Carpizo, Sergio Ruiz-Llorente, … Maria J. Barrero·bioRxiv·Aug 17, 2018
- Uncovering the Bromodomain Interactome using Site-Specific Azide-Acetyllysine Photochemistry, Proteomic Profiling and Structural Characterization
K. Islam, S. Wagner, … E. Fedorov·bioRxiv·Jul 28, 2021
- Identification of novel natural product inhibitors of BRD4 using high throughput virtual screening and MD simulation
Soumen Barman, Snehasudha S. Sahoo, … Babu Sudhamalla·Journal of Biomolecular Structure and DynamicsPeer-reviewed·Dec 16, 2022